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Available online 18 June 2016It was ever thought that genomic information is transmitted
faithfully from generation to generation. But our current
knowledge does not indicate that it is the case. For example,
genomic variations can be generated from DNA replication
infidelity and unequal chromosome segregation. Natural decay
of DNA molecules is also a fundamental source of changing
genomic information. In addition, cellular and organismal
exposure to exogenous genotoxic agents such as ultraviolet
(UV) light, oxidative stress, chemical mutagens, and radiation
can lead to a variety of modifications on DNA constituents,
resulting in genome alterations. Fortunately, cells have evolved
several response systems to tackle numerous DNA lesions in
order to maintain their genome integrity. Among them, check-
point control is probably the most well-known one. For exam-
ple, checkpoint responds to replication stress, replication fork
stalling, double-strand DNA breaks, and various other types
of DNA lesions. Increasing experimental evidence indicates
that genomic instability is probably the fundamental reason
for carcinogenesis. Genomic instability is also found to be a
main etiological factor of neurodegenerative diseases, aging,
immunodeficiency, etc. Thus, to understand how cells regulate
to maintain their genomic stability is of fundamental
importance.The Nobel Prize in Chemistry 2015 was jointly awarded to
Tomas Lindahl, Paul Modrich, and Aziz Sancar for their
mechanistic studies of DNA repair. The journal Genomics,
Proteomics & Bioinformatics (GPB) has thus compiled a special
issue Genome Stability following the award announcement.
Six mini-reviews are included in this special issue, which cover
various aspects of mechanisms underlying the maintenance of
genome stability and related diseases. These are designed to
introduce our readers to the current understanding, research
frontiers, and challenges facing the field.
This special issue starts with a news and views article from
Arne Klungland and Yun-Gui Yang [1]. They briefly intro-
duced the main scientific achievements of Tomas Lindahl in
unraveling fundamental mechanisms of DNA decay and
DNA repair, as well as associations with diseases.
DNA damage is the most important factor that induces
genome instability. When DNA repair processes fail, irrepara-
ble DNA damage including double-strand breaks (DSBs) can
occur. Under normal conditions, DSBs in eukaryotic cells
can be repaired by either homologous recombination (HR)
or non-homologous end-joining (NHEJ) pathways. A vital
step in HR repair is DNA end resection. Liu and Huang [2]
reviewed the machinery involved in DNA end resection and
described in detail the functions of the most important factors
that cooperate to complete the process in eukaryotic cells.
Posttranslational modifications (PTMs) such as phospho-
rylation, acetylation, methylation, ubiquitination, and
SUMOylation are key mechanisms to maintain genome stabil-
ity. Recently some unique PTMs have been shown to be
involved in regulating genome stability. Wei and Yu [3]
reviewed the role of poly ADP-ribosylation (PARylation) innces and
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poly(ADP-ribose) polymerases (PARPs) upon activation by
DNA lesions, forming PAR chains that serve as signals and
docking platforms for DNA repair factors. These authors [3]
highlight the molecular mechanisms of PARylation recogni-
tion, the role of PARylation in DDR pathways, and the func-
tional interaction between PARylation and ubiquitination.
This review offers a better understanding of the biological
roles of this unique PTM in maintaining genome stability.
The review from Dr. Xu’s laboratory [4] is focused on
ubiquitin-fold modifier 1 (UFM1), one of the newly-identified
PTMs. Similar to ubiquitin, UFM1 is conjugated to its target
proteins by a three-step enzymatic reaction, while UFM1 chains
are cleaved from target proteins by UFM1-specific proteases
(UfSPs), suggesting that the UFMylation modification is
reversible. TheUFM1 cascade is associated with several cellular
activities including the endoplasmic reticulum stress response,
hematopoiesis, and certain human diseases. Wei and Xu believe
that this reversible modification process might modulate addi-
tional cellular activities including tumorigenesis and could serve
as potential therapeutic target for cancer treatment.
In addition to protein modifications, post-transcriptional
modifications of RNA also have important regulatory roles
in cellular processes and might be involved in maintaining
genome stability directly or indirectly. Wang and Jia [5]
highlighted the functional role of m6A reader YTHDC1 in
pre-mRNA alternative splicing [6]. Moreover, they also
highlighted two transcriptome-wide sequencing methods to
identify a new mRNA reversible modification, m1A [7,8].
These two studies provided the first transcriptome-wide
methylome map for m1A and suggested potential roles
for this modification [7,8]. We expect that further investigation
of the wider biological functions of m6A and m1A, as well as
the related writer, eraser, and reader proteins, will build a
comprehensive picture of RNA modifications.
Maintenance of tissue-specific stem cells is vital for organ
homeostasis and organismal longevity. DNA lesions are direct
threats to the genome integrity of the stem cell population. The
DDR not only repairs DNA lesions, but also activates orches-
trated signaling pathways, leading to cell cycle regulation, cell
death and senescence, transcriptional regulation, as well as
chromatin remodeling. Recent studies on murine hematopoi-
etic stem cells (HSCs) have indicated that the DDR has impor-
tant roles in the homeostasis of the hematopoietic system in
DDR-deficient mouse models. Li et al. [9] summarized the cur-
rent understanding of how the DDR intrinsically and extrinsi-
cally regulates HSC maintenance, HSC fate determination,
and finally organismal aging.
Mutations in certain components of the DDR machinery
can lead to genomic instability disorders that culminate in
developmental defects, tissue impairment, premature aging,
and cancer. Kaminsky et al. [10] reviewed recent progress on
the role of the DDR in the etiology of various brain degener-
ative diseases (BDDs), and summarized the evidence suggest-
ing that BDDs involve the dysfunction of glial cells.
Malfunctioning glial cells can severely hamper neural-glial
interactions, thereby leading to BDDs.
Li and Liu [11] provided a comprehensive review on the
effect of topoisomerase 1 (TOP1) on genome stability. TOP1
relaxes supercoiled DNA to remove helical constraints that
can otherwise hinder DNA replication and transcription.
Unfortunately, such activity can generate toxic TOP1-DNAcovalent products that can lead to cell death or mutagenesis,
a precursor for tumorigenesis. In an apparent contradiction
to the negative effect of TOP1 activity on genome stability,
the detrimental effect of TOP1-induced DNA lesions on cell
survival has made this enzyme a prime target for cancer ther-
apies to kill fast-growing cancer cells. The impact of TOP1
research on human health is multifold. In this article, they
summarized the current understanding of how TOP1 con-
tributes to human diseases and how its activity can be targeted
for disease treatment.
In conclusion, comprehensive understanding of the mecha-
nisms underlying the DDR will not only help us to discover
new factors for maintaining genome stability, but also shed
light on the development of novel therapeutic strategies for
treatment of diseases. We believe that this special issue will
serve as a valuable resource to update the current status of
genome stability research.
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Wang J and Lindahl T /Maintenance of Genome Stability 121Dr. Tomas Lindahl was the Director of the Clare Hall Laboratories at ICRF and Cancer Research UK (1984–2006). His
research has focused on understanding DNA repair, which has a long-lasting impact on the fields of cancer therapy and
inherited human genetic disorders, among others. Beyond his own outstanding scientific achievements, his stewardship
established Clare Hall Laboratories as an internationally-renowned center of research on DNA processing. The success of
colleagues working together with him is a measure of his insight, support, and leadership. Dr. Lindahl was jointly awarded
the Nobel Prize in Chemistry 2015 for his mechanistic studies on DNA repair.
